D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 40,150
-2,700 (-6.30%)
Oct 12, 2026, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 1.84 trillion as of October 12, 2026. It is the 8,507th most valuable company in the world and the 221st biggest in South Korea. Its market cap has decreased by 15.03% in one year.
Market Cap
1.84T
Enterprise Value
1.80T
Revenue
2.75B
Global Rank
Country Rank
#221 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 1.84T, an increase of 384.87%. That is a compound annual growth rate of 90.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 1.84T | -53.95% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SK bioscience | 2.87T |
| LigaChem Biosciences | 2.70T |
| ABL Bio | 2.69T |
| OliX Pharmaceuticals | 2.67T |
| Voronoi | 2.51T |
| Peptron | 2.13T |
| Hugel | 1.97T |
| Kolon TissueGene | 1.36T |